Genmab — Juni 2018
-
-
Hvad tænker du på Gentogen? Der er da ikke så meget nyt i det Søren Løntoft fortæller.
-
** Danish biotech company Genmab GEN.CO up +3 pct as JP Morgan raises to "overweight" from "neutral"
** Broker still believes that Darzalex peak sales could be USD 9.4 billion, versus previous estimate of USD 9.3 billion
** Broker currently sees positive risk/reward -
JV vil jo nok mene, at det afhænger af, hvor mange penge de har brændt af på pipen og salgsorg. før vi når dertil

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
